Search by Drug Name or NDC

    NDC 00904-6783-70 ASPIRIN LOW DOSE 81 mg/1 Details

    ASPIRIN LOW DOSE 81 mg/1

    ASPIRIN LOW DOSE is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by MAJOR PHARMACEUTICALS. The primary component is ASPIRIN.

    Product Information

    NDC 00904-6783
    Product ID 0904-6783_08f1f37a-725b-e50c-e063-6394a90a72f1
    Associated GPIs 64100010000601
    GCN Sequence Number 016995
    GCN Sequence Number Description aspirin TABLET DR 81 MG ORAL
    HIC3 M9P
    HIC3 Description PLATELET AGGREGATION INHIBITORS
    GCN 00161
    HICL Sequence Number 001820
    HICL Sequence Number Description ASPIRIN
    Brand/Generic Generic
    Proprietary Name ASPIRIN LOW DOSE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aspirin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 81
    Active Ingredient Units mg/1
    Substance Name ASPIRIN
    Labeler Name MAJOR PHARMACEUTICALS
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 00904-6783-70 (00904678370)

    NDC Package Code 0904-6783-70
    Billing NDC 00904678370
    Package 250 TABLET, COATED in 1 BOTTLE (0904-6783-70)
    Marketing Start Date 2018-09-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01455
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ASPIRIN EC 81 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis